FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2099527833> ?p ?o ?g. }

• W2099527833 endingPage "22" @default.
• W2099527833 startingPage "12" @default.
• W2099527833 abstract "TP508 is a 23-amino acid peptide derived from human prothrombin that increases cartilage matrix production and reduces alkaline phosphatase activity without changing chondrocyte proliferation. This study tested the hypothesis that TP508 acts by blocking the onset of apoptosis associated with hypertrophy. Rat costochondral resting zone chondrocytes and human auricular chondrocytes were cultured in DMEM containing 50microM ascorbic acid and 10% FBS. Apoptosis was induced by treatment of confluent cultures with chelerythrine, tamoxifen, or inorganic phosphate (Pi) for 24h. One half of the cultures received TP508 (0, 0.7, or 7microg/ml). Apoptosis was assessed as a function of DNA fragmentation ([3H]-thymidine labeled DNA fragments), TUNEL staining, and cell viability using the MTT assay, as well as by assessing the Bcl-2/Bax mRNA and protein ratios and caspase-3 activity. The universal NO synthase inhibitor l-NMMA was used to assess the effect of NO production on chondrocyte apoptosis and specific NO synthase subspecies were identified using iNOS inhibitor 1400W and nNOS inhibitor vinyl-l-NIO, as well as l-NAME, which inhibits both iNOS and eNOS. Finally, we assessed if TP508 would block NO production induced by the apoptogens. Chelerythrine, tamoxifen and Pi-induced apoptosis and this was reversed by TP508. All apoptogens increased NO production and this was reduced by TP508. TP508 reduced NO levels to the same extent as 1400W but not to the same extent as l-NAME, suggesting that its effects are mediated primarily by iNOS. In addition, TP508 reduced the effect of chelerythrine to the same extent as 1400W and l-NAME, again indicating that it acts via inhibition of an iNOS pathway. TP508 also regulated Bcl-2/Bax mRNA in a time and dose-dependent manner. The Bcl-2/Bax mRNA ratio was 0.11 in the absence of TP508 at 1h and 4.95 at 7microg/ml TP508; by 3h the ratio was approximately 1 in both groups. The Bcl-2/Bax protein ratio also increased by 63% at 1h. TP508 did not affect caspase-3 activity. TP508 also caused a dose-dependent increase in protein kinase C (PKC) activity within 9min that was maximal at 270min. These results show that TP508 prevents apoptosis in growth plate chondrocytes via inhibition of iNOS-dependent NO and suggest a possible role for PKC in the mechanism." @default.
• W2099527833 created "2016-06-24" @default.
• W2099527833 creator A5000398995 @default.
• W2099527833 creator A5011246484 @default.
• W2099527833 creator A5029880479 @default.
• W2099527833 creator A5037634406 @default.
• W2099527833 creator A5052368052 @default.
• W2099527833 creator A5087840084 @default.
• W2099527833 date "2008-01-01" @default.
• W2099527833 modified "2023-09-27" @default.
• W2099527833 title "Thrombin peptide TP508 prevents nitric oxide mediated apoptosis in chondrocytes in the endochondral developmental pathway" @default.
• W2099527833 cites W1804847573 @default.
• W2099527833 cites W1964519636 @default.
• W2099527833 cites W1967270893 @default.
• W2099527833 cites W1968936958 @default.
• W2099527833 cites W1970912476 @default.
• W2099527833 cites W1974021907 @default.
• W2099527833 cites W1975155665 @default.
• W2099527833 cites W1980528903 @default.
• W2099527833 cites W1982920517 @default.
• W2099527833 cites W1993670763 @default.
• W2099527833 cites W1995675713 @default.
• W2099527833 cites W1999566158 @default.
• W2099527833 cites W2000596150 @default.
• W2099527833 cites W2003409953 @default.
• W2099527833 cites W2007204443 @default.
• W2099527833 cites W2011418006 @default.
• W2099527833 cites W2018624898 @default.
• W2099527833 cites W2018656414 @default.
• W2099527833 cites W2036285233 @default.
• W2099527833 cites W2039739616 @default.
• W2099527833 cites W2041890623 @default.
• W2099527833 cites W2041976200 @default.
• W2099527833 cites W2042962535 @default.
• W2099527833 cites W2052391094 @default.
• W2099527833 cites W2067835575 @default.
• W2099527833 cites W2068711793 @default.
• W2099527833 cites W2069393330 @default.
• W2099527833 cites W2080252781 @default.
• W2099527833 cites W2082839234 @default.
• W2099527833 cites W2084473308 @default.
• W2099527833 cites W2091311058 @default.
• W2099527833 cites W2093920593 @default.
• W2099527833 cites W2096182351 @default.
• W2099527833 cites W2096852922 @default.
• W2099527833 cites W2102753351 @default.
• W2099527833 cites W2103461739 @default.
• W2099527833 cites W2113932471 @default.
• W2099527833 cites W2118571380 @default.
• W2099527833 cites W2139836058 @default.
• W2099527833 cites W2147604626 @default.
• W2099527833 cites W2149833461 @default.
• W2099527833 cites W2199786333 @default.
• W2099527833 cites W2233325915 @default.
• W2099527833 cites W2330721972 @default.
• W2099527833 cites W2342960040 @default.
• W2099527833 cites W97609829 @default.
• W2099527833 doi "https://doi.org/10.1016/j.bbamcr.2007.10.009" @default.
• W2099527833 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18023291" @default.
• W2099527833 hasPublicationYear "2008" @default.
• W2099527833 type Work @default.
• W2099527833 sameAs 2099527833 @default.
• W2099527833 citedByCount "7" @default.
• W2099527833 countsByYear W20995278332013 @default.
• W2099527833 crossrefType "journal-article" @default.
• W2099527833 hasAuthorship W2099527833A5000398995 @default.
• W2099527833 hasAuthorship W2099527833A5011246484 @default.
• W2099527833 hasAuthorship W2099527833A5029880479 @default.
• W2099527833 hasAuthorship W2099527833A5037634406 @default.
• W2099527833 hasAuthorship W2099527833A5052368052 @default.
• W2099527833 hasAuthorship W2099527833A5087840084 @default.
• W2099527833 hasConcept C134018914 @default.
• W2099527833 hasConcept C153911025 @default.
• W2099527833 hasConcept C185592680 @default.
• W2099527833 hasConcept C190283241 @default.
• W2099527833 hasConcept C195794163 @default.
• W2099527833 hasConcept C196795494 @default.
• W2099527833 hasConcept C202751555 @default.
• W2099527833 hasConcept C2776108454 @default.
• W2099527833 hasConcept C2777622882 @default.
• W2099527833 hasConcept C2780783641 @default.
• W2099527833 hasConcept C2781403057 @default.
• W2099527833 hasConcept C2986274086 @default.
• W2099527833 hasConcept C31573885 @default.
• W2099527833 hasConcept C31903555 @default.
• W2099527833 hasConcept C43759708 @default.
• W2099527833 hasConcept C519581460 @default.
• W2099527833 hasConcept C53227056 @default.
• W2099527833 hasConcept C55493867 @default.
• W2099527833 hasConcept C62478195 @default.
• W2099527833 hasConcept C86803240 @default.
• W2099527833 hasConceptScore W2099527833C134018914 @default.
• W2099527833 hasConceptScore W2099527833C153911025 @default.
• W2099527833 hasConceptScore W2099527833C185592680 @default.
• W2099527833 hasConceptScore W2099527833C190283241 @default.
• W2099527833 hasConceptScore W2099527833C195794163 @default.
• W2099527833 hasConceptScore W2099527833C196795494 @default.
• W2099527833 hasConceptScore W2099527833C202751555 @default.

• next